These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia. Sirtori CR; Franceschini G; Gianfranceschi G; Sirtori M; Montanari G; Tremoli E; Maderna P; Colli S; Zoppi F J Lab Clin Med; 1987 Sep; 110(3):279-86. PubMed ID: 3475394 [TBL] [Abstract][Full Text] [Related]
8. [Multicenter clinical, double blind, and randomized study to assess the effectiveness and safety of binifibrate versus gemfibrozil in type IIa, IIb, and IV hyperlipidemia]. Corominas Vilardell A; de Oya Otero M; Escobar Jiménez F; Anguera Vila A; Ariño Armengol B An Med Interna; 1993 Nov; 10(11):537-41. PubMed ID: 8117868 [TBL] [Abstract][Full Text] [Related]
9. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study. Aguilar-Salinas CA; Fanghänel-Salmón G; Meza E; Montes J; Gulías-Herrero A; Sánchez L; Monterrubio-Flores EA; González-Valdez H; Gómez Pérez FJ Metabolism; 2001 Jun; 50(6):729-33. PubMed ID: 11398153 [TBL] [Abstract][Full Text] [Related]
10. Changes in serum and lipoprotein lipids, and apolipoprotein B and A-I, in patients with different types of primary hyperlipoproteinaemia treated with gemfibrozil. Sommariva D; Branchi A; Pini C; Scandiani L; Orlandi S; Fasoli A Int J Clin Pharmacol Res; 1988; 8(5):383-92. PubMed ID: 3068163 [TBL] [Abstract][Full Text] [Related]
11. Management of primary mixed hyperlipidemia with lovastatin. Vega GL; Grundy SM Arch Intern Med; 1990 Jun; 150(6):1313-9. PubMed ID: 2353864 [TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of simvastatin in the treatment of hyperlipidemia]. Lu ZL Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Aug; 21(4):216-8, 253. PubMed ID: 8194433 [TBL] [Abstract][Full Text] [Related]
13. [Cerivastatin-a new synthetic 3-hydroxy-3-methylglutaryl (HMG) inhibitor: effect of 0,2 mg dose in patients with primary hyperlipidemias]. Solov'eva EIu; Rozhkova TA; Tvorogova MG; Kukharchuk VV Ter Arkh; 1999; 71(8):30-4. PubMed ID: 10515032 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. McCrindle BW; Ose L; Marais AD J Pediatr; 2003 Jul; 143(1):74-80. PubMed ID: 12915827 [TBL] [Abstract][Full Text] [Related]
15. [Comparison between lovastatin and gemfibrozil in treatment of primary hyperlipidemias]. Bertolami MC; Martinez TL; Faludi AA; Pinto LE; Melo RS; Bismarck ZF; Batlouni M Arq Bras Cardiol; 1991 May; 56(5):407-12. PubMed ID: 1823741 [TBL] [Abstract][Full Text] [Related]
16. Gemfibrozil in familial and type V hyperlipidaemias. Report of 3 cases. Varthakavi P; Turakhia DP; Sharma S; Salgaonkar DS; Nihalani KD; Joshi VR J Assoc Physicians India; 1990 Nov; 38(11):860-2. PubMed ID: 2079473 [TBL] [Abstract][Full Text] [Related]
17. Fenofibrate of gemfibrozil for treatment of types IIa and IIb primary hyperlipoproteinemia: a randomized, double-blind, crossover study. Insua A; Massari F; Rodríguez Moncalvo JJ; Rubén Zanchetta J; Insua AM Endocr Pract; 2002; 8(2):96-101. PubMed ID: 11942772 [TBL] [Abstract][Full Text] [Related]
18. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia. Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118 [TBL] [Abstract][Full Text] [Related]
19. Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia. Franceschini G; Sirtori M; Vaccarino V; Gianfranceschi G; Chiesa G; Sirtori CR J Lab Clin Med; 1989 Sep; 114(3):250-9. PubMed ID: 2504855 [TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of pravastatin for hyperlipidemia in patients with type 2 diabetes mellitus. Tawata M; Miwa I; Tsuchiya K; Ozawa M; Shindo H; Wakasugi M; Onaya T Arzneimittelforschung; 1995 Jun; 45(6):704-8. PubMed ID: 7646575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]